Spinal anesthesia. Other complications of spinal and epidural anesthesia during pregnancy
Conditions
Interventions
Intervention 1: Intervention group: In this group, 12.5 mg of bupivacaine, manufactured by Aboureihan pharmaceuticals, along with 20 mg of meperidine, manufactured by Caspian pharmaceuticals, were use
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
17 Years to 45 Years
Inclusion criteria
Inclusion criteria: Pregnant women 17 to 45 years of age Class of American Society of Anesthesiologists 1 as or 2
Exclusion criteria
Exclusion criteria: Patient dissatisfaction Coagulopathy Increased intracranial pressure Injection site infection Drastic decrease in intravascular volume Severe sensitivity to anesthetics and opioids Pregnancy hypertension Cesarean section requires blood transfusion Chronic itching Emergency cesarean section due to fetal distress Operation length greater than 1.5 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to reach the T10 anesthesia. Timepoint: During surgery. Method of measurement: Physical examination.;The time to reach the highest level of Dermatome anesthesia. Timepoint: During surgery. Method of measurement: Physical examination.;Anesthesia down to T10 level. Timepoint: During surgery. Method of measurement: Physical examination.;Time to reach full block. Timepoint: After surgery. Method of measurement: Physical examination.;Motor recovery time. Timepoint: After surgery. Method of measurement: Physical examination.;Postoperative drowsiness. Timepoint: After surgery. Method of measurement: Physical examination.;Amount of Diclofenac consumption. Timepoint: After surgery. Method of measurement: check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNeda Noruzi
Zahedan University of Medical Sciences
Outcome results
None listed